Associated Papers
Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.
Smith RA et al.
The Journal of Infectious Diseases, 2022
Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.
Alaoui N et al.
Bmc Research Notes, 2018
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.
Cavaco-Silva J et al.
Plos One, 2014
Natural polymorphisms of integrase among HIV type 1-infected South African patients.
Fish MQ et al.
Aids Research and Human Retroviruses, 2010
Deciphering structural and functional roles of individual disulfide bonds of the mitochondrial sulfhydryl oxidase Erv1p.
Ang SK et al.
The Journal of Biological Chemistry, 2009
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
Low A et al.
Antimicrobial Agents and Chemotherapy, 2009
Evolution of raltegravir resistance during therapy.
Sichtig N et al.
The Journal of Antimicrobial Chemotherapy, 2009
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil.
Passaes CB et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2009
Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.
Myers RE et al.
Journal of Virology, 2008
Select a paper to view details